Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma
Clinical trial NCT00058422 · COMPLETED
Trial details
- NCT number
- NCT00058422
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-10
- Primary completion
- 2019-11-14
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.